SouthCoast Health, Southeast Georgia’s Largest Independent Physician Group, Partners with Privia Medical Group

Published on:

ARLINGTON, Va.––Privia Health (“Privia”) announced today that SouthCoast Health has joined Privia Medical Group – Georgia. SouthCoast Health is the third largest group to join Privia’s national network, which is securing the future of its independent providers.

“We are thrilled to partner with Privia Medical Group,” said John Marrero, Administrator of SouthCoast Health. “This partnership enhances our mission to provide and support quality-driven, cost conscious healthcare that is dependable and focused on patient care. Joining with Privia allows our physicians to maintain their autonomy, while gaining access to Privia’s best-in-kind technology, expanded payer relationships and an unmatched professional network—and ultimately will be able to continue to provide excellent patient care.”

SouthCoast Health was founded in Savannah in 1996 by 16 physicians. The physician-led group has since expanded to more than 100 providers and 19 locations across Georgia and South Carolina. As the first group in the region to attain recognition from the National Committee for Quality Assurance for providing excellent evidence-based care to diabetic and heart/stroke patients, SouthCoast Health is known for its delivery of high-quality care.

“Since expanding to Georgia three years ago, Privia’s rapid growth in the market has delivered significant results. In our first year participating in the CMS Medicare Shared Savings Program, we received a quality score of 100% and earned a 6.1% savings rate, equating to more than $10 million in shared savings,” said Jim Sams, MD, CEO of Privia Medical Group–Georgia. “We are excited by the addition of SouthCoast Health to our group, which underscores our commitment to partnering with like-minded organizations that are focused on improving patient outcomes.”

Privia Medical Group – Georgia’s parent company, Privia Health, includes a network of more than 2,000 providers in multiple states. Privia’s proprietary cloud-based technology platform and innovative approach to patient engagement and physician-driven wellness help to improve healthcare delivery and create healthier patient populations.

“Privia delivers the tools, technology and resources to improve the patient experience and enable independent physician practices to grow and thrive,” said Shawn Morris, CEO of Privia Health. “As a top performer in the region with an expansive multi-specialty provider team, SouthCoast Health is the right partner to continue to build a strong presence in the Georgia market, and do our part to transform healthcare affordability in their community.”

About Privia Health

Privia Health is a national physician organization meeting providers where they are to transform the healthcare delivery experience. Through high-performance physician groups, accountable care organizations, and population health management programs, Privia works in partnership with health plans, health systems and employers to better align reimbursements to quality and outcomes. Our physician-led model, scalable systems and proprietary technology reduce unnecessary healthcare costs, achieve better outcomes, and improve the health of patients we serve. For more information: www.priviahealth.com. @PriviaHealth

Related Content

FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death
FDA issues Class I recall on insertion tubes after manufacturing error

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.